Associate Professor, Neurology, University of Virginia School of Medicine
Neurosurgery
Dr. Benjamin W. Purow, MD
|
|
Give Review
Doctor Benjamin W. Purow, MD is an expert in the field of Neurosurgery. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Benjamin Purow is a published doctor and has 40 publications published. The lastest was: 'Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice.' He accepts all Medicare patients.
Publications
- Molecular Pathways: Targeting Diacylglycerol Kinase Alpha in Cancer.
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
- Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
- Micro-masters of glioblastoma biology and therapy: increasingly recognized roles for microRNAs.
- microRNA-148a Is a Prognostic oncomiR That Targets MIG6 and BIM to Regulate EGFR and Apoptosis in Glioblastoma.
- Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.
- A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival.
- Neuro-oncology: Five new things.
- Diacylglycerol kinase alpha is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
- Hepatocyte growth factor sensitizes brain tumors to c-Met kinase inhibition.
- Oncogenic effects of miR-10b in glioblastoma stem cells.
- Angiogenic inhibition in high-grade gliomas: past, present and future.
- Glioblastoma genetics: in rapid flux.
- Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.
- Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.
- Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
- Novel Anti-Apoptotic MicroRNAs 582-5p and 363 Promote Human Glioblastoma Stem Cell Survival via Direct Inhibition of Caspase 3, Caspase 9, and Bim.
- Hammerhead ribozyme cleavage of hamster prion pre-mRNA in complex cell-free model systems.
- Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
- Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
- Progress report on the potential of angiogenesis inhibitors for neuro-oncology.
- Antiangiogenic therapy for primary and metastatic brain tumors.
- Orthotopic growth of human glioma cells quantitatively and qualitatively influences radiation-induced changes in gene expression.
- Influence of in vivo growth on human glioma cell line gene expression: convergent profiles under orthotopic conditions.
- Bevacizumab in combination with irinotecan for patients with recurrent glioblastoma multiforme.
- Notch inhibitors as a new tool in the war on cancer: a pathway to watch.
- microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
- microRNA-34a is tumor suppressive in brain tumors and glioma stem cells.
- The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.
- MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.
- Advances in the genetics of glioblastoma: are we reaching critical mass?
- Spirituality and pediatric cancer.
- The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?
- Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells.
- Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via microRNA-7.
- A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.
- Neuro-oncology: Isocitrate dehydrogenase mutations in low-grade gliomas.
- Notch-1 regulates transcription of the epidermal growth factor receptor through p53.
- Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice.
Schools
Johns Hopkins University School Of Medicine
National Institutes Of Health
Doctors Specialties
- Neurology
- Neurosurgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Children's National Medical Center - George Washington University -
Johns Hopkins University School of Medicine
Drug Facts
| NPI NUMBER | 1801969902 | |
| NPPES Provider LastName | PUROW | |
| NPPES Provider FirstName | BENJAMIN | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Neurology | |
| Total Claim Count | 329.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801969902 |
| Last Name Of The Provider | PUROW |
| First Name Of The Provider | BENJAMIN |
| View All |
Similar Doctors
|
Dr. Ashok R. Asthagiri, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. John A. Jane Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory A. Helm, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark E. Shaffrey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. W Elias, MD |
|
Dr. Joel M. Trugman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sneha A. Mantri, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Denia Ramirez-Montealegre, MD |
|
|
Dr. Sagi Harnof, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dwight Saulle, MD |
|
|
Mohamed F. Falah |
|
|
Pervez A. Khan, MB BS |